All four of Baxter’s headwinds are company-specific and temporary, with resolutions underway. Baxter International is a ...
Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...
Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...
Interim CEO Brent Shafer highlighted the completion of the Vantive sale as a significant milestone in Baxter's transformation strategy and noted the company's focus on innovation and profitable growth ...
Oct 9 (Reuters) - Baxter International (BAX.N), opens new tab is bringing its hurricane-hit IV manufacturing facility in North Carolina back online in stages, with a goal of restoring 90% to 100% of ...
IV fluid supply disruptions prompt Biden administration to invoke wartime powers to bolster recovery
But Baxter’s North Cove facility is a critical part of the supply chain; it typically produces about 60% of the IV fluids for hospitals across the country. The US Department of Health and Human ...
9monon MSN
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recovery
Earnings Call Insights: Baxter International Inc. (NYSE:BAX) Q4 2024 Interim CEO Brent Shafer highlighted the completion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results